Literature DB >> 32813566

Update on the epidemiology of carbapenemases in Latin America and the Caribbean.

Juan Carlos García-Betancur1, Tobias Manuel Appel1, German Esparza2, Ana C Gales3, Gabriel Levy-Hara4, Wanda Cornistein5, Silvio Vega6, Duilio Nuñez7, Luis Cuellar8, Luis Bavestrello9, Paulo F Castañeda-Méndez10, Juan M Villalobos-Vindas11, María Virginia Villegas1,12.   

Abstract

INTRODUCTION: Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam antibiotics, including carbapenems. Carbapenemase production in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., with and without the co-expression of other β-lactamases is a serious public health threat. Carbapenemases belong to three main classes according to the Ambler classification: class A, class B, and class D. AREAS COVERED: Carbapenemase-bearing pathogens are endemic in Latin America. In this review, we update the status of carbapenemases in Latin America and the Caribbean. EXPERT OPINION: Understanding the current epidemiology of carbapenemases in Latin America and the Caribbean is of critical importance to improve infection control policies limiting the dissemination of multi-drug-resistant pathogens and in implementing appropriate antimicrobial therapy.

Entities:  

Keywords:  Acinetobacter baumannii ; Klebsiella pneumoniae ; Pseudomonas aeruginosa ; Latin America; carbapenem resistance; carbapenem-resistant Enterobacterales (CRE); carbapenemases; carbapenems

Year:  2020        PMID: 32813566     DOI: 10.1080/14787210.2020.1813023

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  8 in total

1.  Multicenter Study of Carbapenemase-Producing Enterobacterales in Havana, Cuba, 2016-2021.

Authors:  Haiyang Yu; María Karla González Molina; Yenisel Carmona Cartaya; Marcia Hart Casares; Meiji Soe Aung; Nobumichi Kobayashi; Dianelys Quiñones Pérez
Journal:  Antibiotics (Basel)       Date:  2022-04-12

2.  Genomic surveillance of Acinetobacter baumannii in the Philippines, 2013-2014.

Authors:  Jeremiah Chilam; Silvia Argimón; Marilyn T Limas; Melissa L Masim; June M Gayeta; Marietta L Lagrada; Agnettah M Olorosa; Victoria Cohen; Lara T Hernandez; Benjamin Jeffrey; Khalil Abudahab; Charmian M Hufano; Sonia B Sia; Matthew T G Holden; John Stelling; David M Aanensen; Celia C Carlos
Journal:  Western Pac Surveill Response J       Date:  2021-10-27

3.  A Retrospective Study of Risk Factors, Mortality, and Treatment Outcomes for Infections with Carbapenemase-Producing Enterobacterales in a Tertiary Hospital in Havana, Cuba.

Authors:  Haiyang Yu; Alberto Hernández González; Gonzalo Estévez Torres; María Karla González Molina; Marcia Hart Casares; Xu Han; Waldemar Baldoquín Rodríguez; Dianelys Quiñones Pérez
Journal:  Antibiotics (Basel)       Date:  2022-07-14

4.  Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries.

Authors:  Juan Carlos García-Betancur; Elsa De La Cadena; María F Mojica; Cristhian Hernández-Gómez; Adriana Correa; Marcela A Radice; Paulo Castañeda-Méndez; Diego A Jaime-Villalon; Ana C Gales; José M Munita; María Virginia Villegas
Journal:  Antibiotics (Basel)       Date:  2022-08-13

5.  Clonal diversity of Acinetobacter clinical isolates producing NDM-type carbapenemase in Cuba, 2013-19.

Authors:  Dianelys Quiñones Pérez; Meiji Soe Aung; Yenisel Carmona Cartaya; María Karla González Molina; Niurka Pereda Novales; Nobumichi Kobayashi
Journal:  IJID Reg       Date:  2022-08-29

Review 6.  The urgent need for metallo-β-lactamase inhibitors: an unattended global threat.

Authors:  Maria F Mojica; Maria-Agustina Rossi; Alejandro J Vila; Robert A Bonomo
Journal:  Lancet Infect Dis       Date:  2021-07-08       Impact factor: 25.071

7.  The Spread of NDM-1 and NDM-7-Producing Klebsiella pneumoniae Is Driven by Multiclonal Expansion of High-Risk Clones in Healthcare Institutions in the State of Pará, Brazilian Amazon Region.

Authors:  Yan Corrêa Rodrigues; Amália Raiana Fonseca Lobato; Ana Judith Pires Garcia Quaresma; Lívia Maria Guimarães Dutra Guerra; Danielle Murici Brasiliense
Journal:  Antibiotics (Basel)       Date:  2021-12-14

Review 8.  β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects.

Authors:  Karl A Glen; Iain L Lamont
Journal:  Pathogens       Date:  2021-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.